Past event
November 2023 Prescription Drug Affordability Board Meeting
Board Meeting
November 27th, 2023 2:00 pm
- Date and time: November 27th, 2023 2:00 pm
Public Comment
The Board has set aside an opportunity for public comment during the meeting. Public comments must concern an agenda item and are limited to one minute and thirty seconds per comment. If you are interested in registering to make a public comment, please email [email protected] no later than the close of business on Monday, November 20, 2023, and provide:
- Your name
- Your address
- The agenda item your comment will address. PDAB staff will reach out to you directly to confirm your reservation or provide additional detail.
Written Comment
The public may also submit written comments on the Board's pending decisions, or general comments regarding the Board's work, to [email protected]. Please submit any written comments concerning this agenda no later than the close of business on Monday, November 20, 2023.
Agenda and Meeting Materials
- Agenda (Updated November 20, 2023) - PDF - 86.9 KB
- Minutes - PDF - 90 KB
- 14.01.01- General Provisions- Final - PDF - 125.83 KB
- 14.01.04 Cost Review Study Process- Redlined - PDF - 134.15 KB
- 14.01.04- Cost Review Study Process- Final - PDF - 134.1 KB
- Presentation- General Provisions and Cost Review Study Process Final Action - PDF - 106.98 KB
- 11.27.2023 Board 2023 Cost Review Report Section 21-2C-09 - PDF - 110.05 KB
- Public Comment.BIO-MTC - PDF - 203.96 KB
- 11.27.2023 Board Public Comment CFF - PDF - 204.71 KB
- Public Comment.HHIV.CANN.TAI - PDF - 281.91 KB
- Public Comment.LA - PDF - 30.83 KB
- Public Comment.LLT.pdf - PDF - 70.79 KB
- Public Comment.MB - PDF - 29.19 KB
- Public Comment.NACDS - PDF - 235.32 KB
Comment Received after Deadline:
Maryland Register Comments Received
- PhRMA Comment Letter 1, May 2023 (resent) - PDF - 450.18 KB
- PhRMA Comment Letter 2, May 2023 (resent) - PDF - 275.1 KB
- PhRMA Comment Letter 3, May 2023 (resent) - PDF - 249.33 KB
- PhRMA Comment Letter, June 2023 (resent) - PDF - 359.94 KB
- PhRMA Comment Letter, October 2023 - PDF - 272.67 KB
- NORD Comment Letter - PDF - 255.84 KB